AIKI
Income statement / Annual
Last year (2024), AIkido Pharma Inc.'s total revenue was $18.15 M,
and the percentage change from the previous year is not available.
In 2024, AIkido Pharma Inc.'s net income was -$14.70 M.
See AIkido Pharma Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$18.15 M |
$0.00 |
$0.00 |
$0.00 |
$9.00 K |
$28.00 K |
$1.24 M |
$877.00 K |
$33.00 K |
$10.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$81.00 K
|
$92.00 K
|
$84.00 K
|
$88.00 K
|
$864.00 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.00 K
|
-$53.00 K
|
$1.14 M
|
$793.00 K
|
-$55.00 K
|
-$854.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
1
|
-1.89
|
0.93
|
0.9
|
-1.67
|
-85.4
|
| Research and Development Expenses |
$0.00
|
$830.00 K
|
$559.00 K
|
$2.49 M
|
$2.52 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$29.67 M
|
$11.68 M
|
$7.73 M
|
$4.06 M
|
$0.00
|
$3.06 M
|
$3.69 M
|
$4.58 M
|
$5.13 M
|
$20.79 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$29.67 M
|
$11.68 M
|
$7.73 M
|
$4.06 M
|
$3.17 M
|
$3.06 M
|
$3.69 M
|
$4.58 M
|
$5.13 M
|
$20.79 M
|
| Other Expenses |
$0.00
|
$1.83 M
|
$1.15 M
|
$1.47 M
|
$0.00
|
$1.44 M
|
$1.37 M
|
$2.14 M
|
$6.32 M
|
$9.83 M
|
| Operating Expenses |
$29.67 M
|
$14.35 M
|
$9.44 M
|
$6.55 M
|
$5.69 M
|
$4.50 M
|
$5.06 M
|
$6.72 M
|
$11.44 M
|
$30.62 M
|
| Cost And Expenses |
$0.00
|
$14.35 M
|
$9.44 M
|
$6.55 M
|
$5.69 M
|
$4.50 M
|
$5.06 M
|
$6.72 M
|
$11.44 M
|
$30.62 M
|
| Interest Income |
$960.00 K
|
$687.00 K
|
$252.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$7.76 M
|
-$2.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
-$188.00 K
|
$2.27 M
|
-$5.79 M
|
$1.50 M
|
$1.44 M
|
$1.38 M
|
$2.14 M
|
$6.32 M
|
$9.83 M
|
| EBITDA |
-$11.53 M |
-$14.35 M |
-$7.17 M |
-$12.34 M |
-$4.18 M |
$3.17 M |
-$1.93 M |
-$4.34 M |
-$45.15 M |
-$20.70 M |
| EBITDA Ratio |
-0.64
|
0
|
0
|
0
|
-464.78
|
113.21
|
-1.56
|
-4.95
|
-1368.09
|
-2070.1
|
| Operating Income Ratio |
-0.64
|
0
|
0
|
0
|
-631.67
|
-245.5
|
-3.09
|
-9.75
|
-1576.06
|
-3061.1
|
| Total Other Income/Expenses Net |
-$3.18 M
|
-$7.76 M
|
$2.27 M
|
-$5.79 M
|
$1.50 M
|
$8.60 M
|
$516.00 K
|
$2.08 M
|
$545.00 K
|
$79.00 K
|
| Income Before Tax |
-$14.70 M
|
-$22.11 M
|
-$7.17 M
|
-$12.34 M
|
-$4.18 M
|
$1.73 M
|
-$3.31 M
|
-$6.48 M
|
-$51.47 M
|
-$30.53 M
|
| Income Before Tax Ratio |
-0.81
|
0
|
0
|
0
|
-464.78
|
61.68
|
-2.67
|
-7.38
|
-1559.55
|
-3053.2
|
| Income Tax Expense |
$0.00
|
$7.76 M
|
-$2.27 M
|
$0.00
|
$0.00
|
$8.60 M
|
$516.00 K
|
$2.08 M
|
$545.00 K
|
$79.00 K
|
| Net Income |
-$14.70 M
|
-$29.87 M
|
-$4.90 M
|
-$12.34 M
|
-$4.18 M
|
$1.73 M
|
-$3.31 M
|
-$6.48 M
|
-$51.47 M
|
-$30.53 M
|
| Net Income Ratio |
-0.81
|
0
|
0
|
0
|
-464.78
|
61.68
|
-2.67
|
-7.38
|
-1559.55
|
-3053.2
|
| EPS |
-2.38 |
-5.6 |
-2.97 |
-7.47 |
-28.31 |
15.48 |
-43.13 |
-126.45 |
-2195.79 |
-2123.52 |
| EPS Diluted |
-2.38 |
-5.6 |
-2.97 |
-7.47 |
-28.31 |
15.48 |
-43.13 |
-121.9 |
-2195.79 |
-2123.52 |
| Weighted Average Shares Out |
$6.18 M
|
$5.33 M
|
$1.65 M
|
$1.65 M
|
$147.74 K
|
$111.57 K
|
$76.66 K
|
$51.21 K
|
$23.44 K
|
$14.38 K
|
| Weighted Average Shares Out Diluted |
$6.18 M
|
$5.33 M
|
$1.65 M
|
$1.65 M
|
$147.74 K
|
$111.57 K
|
$76.66 K
|
$53.13 K
|
$23.44 K
|
$14.38 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
